Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 505560
                    [Title] => Cheaper HIV/AIDS treatments in developing nations
                    [Summary] => 
NEW YORK — Former US President Bill Clinton recently announced two important and complementary agreements to enable better, more affordable treatments for patients on second-line antiretroviral (ARV) therapy for HIV/AIDS in the developing world. 
                    [DatePublished] => 2009-09-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 503161
                    [Title] => Unending Pfizer woes?
                    [Summary] => 
Multinational pharmaceutical firm Pfizer is reeling under a tsunami of woes again as international media bannered last week a settlement offer it made in the face of massive lawsuits arising from its marketing of the controversial drug Bextra.
                    [DatePublished] => 2009-09-09 00:00:00
                    [ColumnID] => 134315
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

JEFFREY KINDLER

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 505560
                    [Title] => Cheaper HIV/AIDS treatments in developing nations
                    [Summary] => 
NEW YORK — Former US President Bill Clinton recently announced two important and complementary agreements to enable better, more affordable treatments for patients on second-line antiretroviral (ARV) therapy for HIV/AIDS in the developing world. 
                    [DatePublished] => 2009-09-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 503161
                    [Title] => Unending Pfizer woes?
                    [Summary] => 
Multinational pharmaceutical firm Pfizer is reeling under a tsunami of woes again as international media bannered last week a settlement offer it made in the face of massive lawsuits arising from its marketing of the controversial drug Bextra.
                    [DatePublished] => 2009-09-09 00:00:00
                    [ColumnID] => 134315
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

abtest

Cheaper HIV/AIDS treatments in developing nations

September 17, 2009 - 12:00am

NEW YORK — Former US President Bill Clinton recently announced two important and complementary agreements to enable better, more affordable treatments for patients on second-line antiretroviral (ARV) therapy...

Science and Environment

Unending Pfizer woes?

September 9, 2009 - 12:00am

Multinational pharmaceutical firm Pfizer is reeling under a tsunami of woes again as international media bannered last week a settlement offer it made in the face of massive lawsuits arising from its marketing of...

Business